by Linda Cheek, MD | Dec, Sun, 2020 | Legislative, Uncategorized |
“Marijuana Opportunity Reinvestment and Expungement Act of 2019” The More Act passed the House Dec 4, 2020. There appears to be a lot of misunderstanding in the CPP community as to what this bill can do for them if it could just be passed into law. I will try to...
by Linda Cheek, MD | Nov, Mon, 2020 | Advocacy |
On November 6, 2020, an article by Malini Ghoshal, Hanna Shapiro, Knox Todd, and Michael E. Schatman was published in the Journal of Pain Research. In the article, they point out the blatant discrimination against Blacks, Indians, and People of Color (BIPOC) who seek...
by Linda Cheek, MD | Nov, Mon, 2020 | Advocacy |
This is the wave we need to use in our fight. We need to accept the fact that pain patients won’t work together, and use other organizations to get the job done. The current wave of acceptance of marijuana and cannabis is one such wave. This election, Oregon passed...
by Linda Cheek, MD | Oct, Thu, 2020 | Medicine |
Data analytics companies are growing in the business market. It has become quite competitive. One thing I’ve noticed about the two main companies focusing on heath records and data is that they are registered as 501 (c)(3) nonprofits. I personally don’t see how...
by Linda Cheek, MD | Oct, Thu, 2020 | Medicine |
So do you know your Narx Score? First, what is the Narx Score? How did it come about? In 2011, a company in Louisville, KY—Appriss—had their first meeting to begin the development of the analytics of PDMP data creating the Narx Score. The Narx Score is a numeric...